ReviewJournal of personalized medicine2026

The Dawn of Precision Medicine in Pediatric Nephrology: Lumasiran and the Era of siRNA Therapies for Primary Hyperoxaluria Type 1.

John Dotis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.